Taysha Gene Therapies Inc (TSHA)
1.24
-0.10
(-7.46%)
USD |
NASDAQ |
Nov 05, 10:26
Taysha Gene Therapies Market Cap: 254.13M for Nov. 5, 2024
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| November 04, 2024 | 274.62M |
| November 01, 2024 | 313.56M |
| October 31, 2024 | 346.35M |
| October 30, 2024 | 383.24M |
| October 29, 2024 | 385.29M |
| October 28, 2024 | 403.74M |
| October 25, 2024 | 407.84M |
| October 24, 2024 | 403.74M |
| October 23, 2024 | 403.74M |
| October 22, 2024 | 407.84M |
| October 21, 2024 | 413.99M |
| October 18, 2024 | 422.18M |
| October 17, 2024 | 416.03M |
| October 16, 2024 | 416.03M |
| October 15, 2024 | 399.64M |
| October 14, 2024 | 407.84M |
| October 11, 2024 | 411.94M |
| October 10, 2024 | 405.79M |
| October 09, 2024 | 409.89M |
| October 08, 2024 | 411.94M |
| October 07, 2024 | 405.79M |
| October 04, 2024 | 411.94M |
| October 03, 2024 | 413.99M |
| October 02, 2024 | 420.13M |
| October 01, 2024 | 413.99M |
| Date | Value |
|---|---|
| September 30, 2024 | 411.94M |
| September 27, 2024 | 424.23M |
| September 26, 2024 | 430.38M |
| September 25, 2024 | 411.94M |
| September 24, 2024 | 422.18M |
| September 23, 2024 | 416.03M |
| September 20, 2024 | 440.63M |
| September 19, 2024 | 448.83M |
| September 18, 2024 | 440.63M |
| September 17, 2024 | 446.78M |
| September 16, 2024 | 444.73M |
| September 13, 2024 | 469.32M |
| September 12, 2024 | 448.83M |
| September 11, 2024 | 475.47M |
| September 10, 2024 | 469.32M |
| September 09, 2024 | 469.32M |
| September 06, 2024 | 418.08M |
| September 05, 2024 | 432.43M |
| September 04, 2024 | 424.23M |
| September 03, 2024 | 422.18M |
| August 30, 2024 | 459.07M |
| August 29, 2024 | 440.63M |
| August 28, 2024 | 428.33M |
| August 27, 2024 | 438.58M |
| August 26, 2024 | 442.68M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
37.87M
Minimum
Jun 28 2023
1.199B
Maximum
Jan 20 2021
433.68M
Average
418.34M
Median
Market Cap Benchmarks
| CEL-SCI Corp | 50.38M |
| AIM ImmunoTech Inc | 15.89M |
| IGC Pharma Inc | 28.36M |
| NovaBay Pharmaceuticals Inc | 3.713M |
| Protalix BioTherapeutics Inc | 94.87M |
Market Cap Related Metrics
| PS Ratio | 18.70 |
| Price to Book Value | 2.334 |
| Price | 1.24 |
| Earnings Yield | -69.73% |